Catherine Bruyns

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

Catherine Gérard, Catherine Bruyns, Arnaud Marchant et al. · The Journal of Experimental Medicine · 1993 · 800 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +17

Interleukin‐10 controls interferon‐γ and tumor necrosis factor production during experimental endotoxemia

Arnaud Marchant, Catherine Bruyns, Peter Vandenabeele et al. · European Journal of Immunology · 1994 · 297 citations

Life Sciences, Immunology, Pathology +17

The P2Y11 Receptor Mediates the ATP-Induced Maturation of Human Monocyte-Derived Dendritic Cells

Françoise Wilkin, Xavier Duhant, Catherine Bruyns et al. · The Journal of Immunology · 2001 · 193 citations

Life Sciences, Immunology, Pharmacology +17

Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate

Margarita Salcedo, Nadège Bercovici, Rachel R. Taylor et al. · Cancer Immunology Immunotherapy · 2005 · 139 citations · Full text

Medicine, Immunology, Oncology +16

MHC class II expression and potential antigen-presenting cells in the retina during experimental autoimmune uveitis

Deborah Lipski, Rémi Dewispelaere, Vincent Foucart et al. · Journal of Neuroinflammation · 2017 · 97 citations · Full text

Medicine, Immunology, Ophthalmology +17